Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+1,74%
1 094,84
+18,71
+1,74%
—1 076,131 079,891 100,771 079,89——
SIXC
Communications
SIXC
Communications
SIXC
-0,42%
604,21
-2,53
-0,42%
—606,74606,74607,90602,03——
SIXE
Energy
SIXE
Energy
SIXE
+0,07%
1 249,71
+0,89
+0,07%
—1 248,821 246,371 256,421 239,08——
SIXI
Industrials
SIXI
Industrials
SIXI
+0,86%
1 739,26
+14,90
+0,86%
—1 724,361 733,021 745,751 727,76——
SIXM
Financials
SIXM
Financials
SIXM
+0,01%
635,63
+0,040
+0,01%
—635,59635,08637,96633,31——
SIXR
Staples
SIXR
Staples
SIXR
+0,61%
848,32
+5,17
+0,61%
—843,15842,50852,77840,85——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0,22%
216,76
+0,47
+0,22%
—216,29216,29217,30215,24——
SIXT
Technology
SIXT
Technology
SIXT
+2,20%
3 335,14
+71,73
+2,20%
—3 263,413 296,253 343,663 295,42——
SIXU
Utilities
SIXU
Utilities
SIXU
+0,01%
939,34
+0,10
+0,01%
—939,24941,57948,11939,11——
SIXV
Health care
SIXV
Health care
SIXV
+0,38%
1 468,17
+5,61
+0,38%
—1 462,561 465,031 471,561 459,66——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,28%
2 387,09
+6,69
+0,28%
—2 380,402 394,922 412,132 386,82——
PVCT:OTCMKTS
Provectus Biopharmaceuticals Inc
USD 0,061
+4,72%
(+0,0028) 1D
5 Mei, 15:29:09 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PVCT...
Open
USD 0,06
High
USD 0,07
Low
USD 0,06
Mkt. cap
24,51 m
Avg. vol.
209,40 k
Volume
142,00 k
52-wk high
USD 0,10
52-wk low
USD 0,04
EPS
-USD 0,01
Beta
0,81
Shares outstanding
420,28 m
No. of employees
6
News stories
From sources across the web
About Provectus Biopharmaceuticals Inc
CEO-
Employees6
Founded2002
HeadquartersKnoxville, Tennessee, Verenigde State van Amerika
SectorPharmaceutical industry
Websiteprovectusbio.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mrt. 2025
Jun. 2025
Sep. 2025
Des. 2025
Revenue
278,63 k
57,48 k
-
-
Cost of goods sold
380,66 k
858,90 k
323,22 k
248,94 k
Cost of revenue
380,66 k
858,90 k
323,22 k
248,94 k
Research and development expenses
-
-
13,64 k
13,64 k
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
874,88 k
874,18 k
831,08 k
761,24 k
Operating expense
874,88 k
874,18 k
844,72 k
774,88 k
Total operating expenses
1,26 m
1,73 m
1,17 m
1,02 m
Operating income
-976,92 k
-1,68 m
-1,17 m
-1,02 m
Other non operating income
-
-
-
-
EBT including unusual items
-1,16 m
-1,85 m
-1,32 m
-1,17 m
EBT excluding unusual items
-1,04 m
-1,73 m
-1,22 m
-1,07 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1,14 m
-1,81 m
-1,31 m
-1,17 m
Net profit margin
-409,19%
-3 156,61%
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-63,66 k
-51,35 k
-48,02 k
-47,32 k
Net interest expenses
-63,66 k
-51,35 k
-48,02 k
-47,32 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-976,45 k
-1,68 m
-1,17 m
-1,02 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer